Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Accept all cookies Reject all non-essential cookies Find out more

Publications

The impact of the UK COVID-19 lockdown on the screening, diagnostics and incidence of breast, colorectal, lung and prostate cancer in the UK: a population-based cohort study

Barclay NL. et al, (2024), Frontiers in oncology, 14

The effectiveness of COVID-19 vaccines to prevent long COVID symptoms: staggered cohort study of data from the UK, Spain, and Estonia.

Català M. et al, (2024), Lancet respir med, 12, 225 - 236

Observational methods for COVID-19 vaccine effectiveness research: an empirical evaluation and target trial emulation.

Català M. et al, (2024), Int j epidemiol, 53

Supporting Pharmacovigilance Signal Validation and Prioritization with Analyses of Routinely Collected Health Data: Lessons Learned from an EHDEN Network Study.

Gauffin O. et al, (2023), Drug saf, 46, 1335 - 1352

"The burden of post-acute COVID-19 symptoms in a multinational network cohort analysis".

Kostka K. et al, (2023), Nat commun, 14

Collateral effects of the COVID-19 pandemic on endocrine treatments for breast and prostate cancer in the UK: implications for bone health

Barclay NL. et al, (2023)

Drug utilization analysis of osteoporosis medications in seven European electronic health databases.

Tan EH. et al, (2023), Osteoporos int, 34, 1771 - 1781

Risk of adverse events following the initiation of antihypertensives in older people with complex health needs: a self-controlled case series in the United Kingdom.

Jödicke AM. et al, (2023), Age ageing, 52

The Impact of the UK COVID-19 Lockdown on the Screening, Diagnostics and Incidence of Breast, Colorectal, Lung and Prostate Cancer in the UK: a Population-Based Cohort Study

Barclay NL. et al, (2023)

HLA Alleles, COVID-19 Vaccine Antibody Response and Real-World Breakthrough Outcomes

Prieto-Alhambra D. et al, (2023)

The role of COVID-19 vaccines in preventing post COVID-19 thromboembolic and cardiovascular complications: a multinational cohort study

Mercadé-Besora N. et al, (2023)

The Effectiveness of COVID-19 Vaccines to Prevent Long COVID Symptoms: Staggered Cohort Analyses of Data from the UK, Spain, and Estonia

Catala Sabate M. et al, (2023)

The burden of long COVID: a multinational cohort analysis of Spanish and UK data including SARS-CoV-2 infections, reinfections, and matched contemporaneous test negative controls

Kostka K. et al, (2023)

Characterising complex health needs and the use of preventive therapies in the older population: a population-based cohort analysis of UK primary care and hospital linked data

ELHUSSEIN L. et al, (2023), Bmc geriatrics

Characterising the treatment of thromboembolic events after COVID-19 vaccination in 4 European countries and the US: An international network cohort study.

Markus AF. et al, (2023), Front pharmacol, 14

Observational methods for COVID-19 vaccine effectiveness research: a trial emulation and empirical evaluation

Catala Sabate M. et al, (2022)

Validation of Algorithms to Identify Acute Myocardial Infarction, Stroke, and Cardiovascular Death in German Health Insurance Data

Platzbecker K. et al, (2022), Clinical epidemiology

Characterising complex health needs and the use of preventative therapies in the older population: a population-based cohort analysis of UK primary care and hospital linked data

Elhussein L. et al, (2022)

Oral bisphosphonates are associated with increased risk of severe acute kidney injury in elderly patients with complex health needs: a self-controlled case series in the UK.

Oda T. et al, (2022), J bone miner res

Abstracts of the 37th International Conference on Pharmacoepidemiology & Therapeutic Risk Management, Virtual, August 23, 2021.

(2021), Pharmacoepidemiol drug saf, 30 Suppl 1, 3 - 439

Load More